Market Overview:

The global proteomics market is a vibrant and booming sector of the overall biotechnology industry. Application of technology for identifying and quantifying the total amount of proteins in a cell, tissue, or organism is known as proteomics. It is a companion to other “omics” technologies such as transcriptomics or genomics for identifying proteins in an organism and understanding their structure and functions. Furthermore, the development in proteomics will drive drug discovery and other studies. 

Market Size Growth Rate:

According to the DataM market research report, the global proteomics market size is valued at USD 31.9 billion in 2022, it is expected to reach USD 83.1 billion by 2030, with growth at a CAGR of 13.1% over the forecast period 2023-2030. North America is estimated to contribute 42.1% to the growth of the global market over the forecast period.

The global proteomics market is driven by factors such as the huge amount of researches on proteomics for clinical applications, technological advancements, growing utilization of advanced instruments, the rising applications of proteomics in various fields such as genomics, and expansion of market due to novel product launches. On the other hand, the high cost and limitations associated with the proteomics technology restrain market growth.

 

For More Insights about the Market Request free Sample: https://www.datamintelligence.com/download-sample/proteomics-market

 

Market Drivers:

The growing number of research on biomarkers usage for cancer and technological advances is propelling the global demand for proteomics. Innovative medical procedures made possible by developments in proteomic technologies include protein biochips, pharmacoproteomics, and molecular diagnostics based on proteomics. These innovations have had a significant impact on the advancement of personalized medicine. 

Nanoproteomics, which uses nanobiotechnology to apply proteomics, has improved applicability in customized medicine. In order to diagnose some illnesses and comprehend the pathomechanism of disease, proteomics-based molecular diagnostics will be crucial. The combination of diagnostics and therapies will be crucial for promoting personalized medicine, and proteomics will serve as a useful bridge in this regard. Utilizing proteomic biomarkers and combining pharmacogenomics with pharmacoproteomics will improve patient monitoring and enable stratification of clinical trials for the creation of individualized medicines.  

Market Restraints:

It is anticipated that the proteomics market may hamper due to the high cost and limitations associated with proteomic technology. The complexity of the evaluation, the lack of uniformity in sample processing, the possibility of significant false positivity, the variability of the sample, which limits the calculation of low protein abundance, the unavailability of the analysis software owing to its propriety, the challenge in establishing the threshold among signal and noise, poor reproducibility, the absence of stringent statistics application, protein hindrance ignorance and signal suppression by specialized tissue expression are some of the limitations of proteomics. These factors may restrain the market’s growth.

Market Opportunities:

The development and expansion in the field of proteomics by key players via partnership or collaborations provide a significant potential opportunity for researchers studying proteomics for novel drug discovery. For instance, in November 2021, Thermo Fisher Scientific Inc., announced that proteomics workflows are being improved in terms of throughput, thoroughness, and quality for uses like single-cell studies as well as translational research. In order to supply laboratories conducting high-throughput plasma research with cutting-edge and streamlined kits, instruments, and software for creating accurate and effective workflows at scale, Thermo Fisher has extended their collaborative marketing contract with Biognosys, a provider of next-generation proteomics solutions. 

 

View Full Report: https://www.datamintelligence.com/research-report/proteomics-market

 

COVID-19 Impact Analysis:

During the pandemic, the main topics of public health focus were COVID-19 prevention and transmission. The demand for proteomics has been impacted by the reduction or redirection of awareness campaigns and efforts aimed at oncology and other chronic disease. As of 2023, the COVID-19 situation is recovering and all patients can access healthcare facilities which drive the demand for the Proteomics worldwide. 

Russia-Ukraine War Impact Analysis:

Due to the low prevalence as well as absence of major market participants in this region, it is predicted that the Russia-Ukraine conflict will not have a significant effect on the worldwide proteomics market. The growth of the global proteomics market, however, is anticipated to be relatively unaffected by the import and export of raw materials over the forecast period.

Recent Developments in the Industry:

1. On January 26, 2023, during the WCBP conference in Washington, D.C., Bio-Techne Corporation announced the release of MauriceFlex under the ProteinSimple brand. With the ability to perform regular cIEF & CE-SDS experiments as well as protein charge variant fractionation, MauriceFlex is a special multi-functional instrument that significantly simplifies protein characterisation operations. For extended characterization, the MauriceFlex fractionation allows for direct examination of collected fractions without the need for sample preparation for mass spectrometry.
2. On June 5, 2023, Orbitrap Astral mass spectrometer by Thermo Scientific is one of the most important developments in mass spectrometry in the last 15 years, according to Thermo Fisher Scientific Inc., an international leader in providing science services. Researchers from all across the world may now identify proteins that have previously eluded detection and produce ground-breaking discoveries more quickly than ever thanks to the new Astral analyzer, which combines rapid throughput, high sensitivity, and comprehensive proteome coverage. 
3. On October 18, 2022, in order to offer an integrated CE-MS solution to the life science and pharmaceutical industries, CMP Scientific Corp., a pioneer in Capillary Electrophoresis-Mass Spectrometry (CE-MS) technology, announced that it has entered a global co-marketing agreement with Agilent technology. In the life sciences, diagnostics, and applied sectors, CMP Scientific develops, produces, and sells goods and analytical instruments. In order to develop new uses for the CE-MS technology, which is a sensitive alternative to liquid chromatography-mass spectrometry (LC-MS) for mapping biological components, CMP and Agilent will collaborate.

Market Segmentation:

As per the research analysis, the global proteomics market is segmented by instrumentation technology (chromatography, protein microarrays, spectroscopy, electrophoresis, x-ray crystallography, surface plasmon resonance, protein fractionation and others), by application (drug discovery, clinical diagnostics and others), by services and software (bioinformatics software and services, core proteomics services and reagents), by end user (hospitals, research laboratories and biopharmaceutical companies).

1. Based on instrumentation technology, the spectroscopy segment is estimated to contribute 26.8% to the growth of the global market over the forecast period (2023-2030). Established on ion-charge ratio, mass spectrometry is a useful technique for finding, classifying, and quantifying compounds. In proteomics, mass measurement provides details regarding the structure, chemical changes, and identification of the protein. 
2. Three major parts make up any mass spectrometer: the source, the analyzer, and the detector. The ability of the source to create ions, the analyzer to separate the ions based on their mass (mass-to-charge ratio), and the detector to identify charged particles and increase the response to provide a measurable signal are all requirements for mass spectrometers. 
3. Due to its accuracy in these processes, mass spectrometry has developed into a valuable instrument to assess in many biopharmaceutical companies and research groups. With the rising prevalence of chronic disorders and advances in cancer treatment using biomarkers, the demand for proteomics is expected to expand, resulting in safe and effective cancer treatment.

Geographical Classification:

The global proteomics market is segmented into major countries, including North America, Europe, South America, Asia Pacific, and Middle East & Africa.

North America Proteomics Market:

The presence of huge number of key players settled in the region, technological advancements and high research activities along with developments of novel instrument and software for proteomics research by major players in the area makes it the highest market shareholder in proteomics market. The demand for proteomics in the pharmaceutical as well as biotechnology industry is driven by an increase in the amount of software and technologies and rising product launch for laboratory usage in the region.

Asia-Pacific Proteomics Market:

Various novel advancements are taking place in the region including expansion and advancements in research. For instance, on December 22, 2022, Agilent Technologies Inc. has announced the inauguration of a brand-new, full-scale Integrative Biology Center at Malaysia’s Monash University, with the goal of fostering local capacity to quicken scientific research and development (R&D). The facility, which is located at the Jeffrey Cheah School of Medicine or Health Sciences of university at Sunway, is furnished with Agilent’s complete operation solutions, such as mass spectrometry (LC/MS), high-performing liquid chromatography and gas chromatography (GC/MS) infrastructure, to offer analytical services in applied biology research for journals and prospective clinical use. 

Europe Proteomics Market:

Strict regulatory standards apply to pharmaceutical systems and products in Europe. Before being approved and released onto the market, medical device, instruments and other systems must pass stringent safety and efficiency tests. High regulatory criteria are followed, which guarantees the quality of the products and increases consumer confidence. Also, the increasing research on proteomics and growing number of approvals drive the market in this region.

Competitive Analysis:

The global proteomics market has a large number of regional, local, and international vendors. The local market is rife with competition. Based on price, product quality, and dependability, the vendors compete. As a result, suppliers must offer items that are both affordable and efficient if they want to thrive and survive in a cutthroat market.

Major Companies:

Major companies working towards the market’s growth include Thermo Fisher Scientific Inc., Danaher, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Bruker, Merck KGaA, Promega Corporation, Waters Corporation, PerkinElmer Inc., MaxCyte and others.  

Related Reports

• Global High-performance Liquid Chromatography (HPLC) Market
• Global Capillary Electrophoresis Market

Additional Benefits Post Purchase:

1) Unlimited Analyst support for a period of 1 year. 

2) Any query with regard to the scope offered will be addressed within 24- 48 hours.

3) An Excel sheet with market numbers will be provided separately.

The Full Report has the below insights: 

• The report offers a comprehensive evaluation of the market in terms of market value (US) and Y-o-Y Growth Rates (%). It does so via in-depth qualitative insights, historical data (2021-2022), and verifiable projections about market size during the forecast period (2023-2030).
• Visualize the composition of the global proteomics market segmentation by instrumentation technology, application, services and software, end-user and region, highlighting the key commercial assets and players. 
• By Instrumentation Technology: Chromatography (HPLC, Ion Chromatography, Affinity Chromatography, Supercritical Fluid Chromatography), Protein Microarrays (Biochips {Lab-On-Chips (Microfluidics), Protein Chips}, Microarray Instruments {Microarray Scanners, Arrayers}), Spectroscopy (Mass Spectroscopy, NMR Spectroscopy, CD Spectroscopy), Electrophoresis (Gel Electrophoresis, Capillary Electrophoresis), X-Ray Crystallography, Surface Plasmon Resonance, Protein Fractionation and Others.
• By Application: Drug Discovery, Clinical Diagnostics and Others.  
• By Services and Software: Bioinformatics Software and Services (Bioinformatics Services, Bioinformatics Tools and Bioinformatics Databases), Core Proteomics Services (Protein Identification Services, Protein Characterization Services, Quantitative Proteomics Services, Protein Purification Services, Protein Separation Services, Protein Sequencing Services, Custom Assay Services) and Reagents. 
• By End User: Hospitals, Research Laboratories and Biopharmaceutical Companies.
• By Region: North America, South America, Europe, Asia Pacific, Middle East & Africa.
• Identify commercial opportunities in the global proteomics market by analyzing trends and co-development deals.
• The report also covers data insights on various industry forces such as porter’s five forces analysis, supply chain analysis, pricing analysis, and regulatory analysis.
• Excel data sheet with thousands of data points of global proteomics market-level 4/5 segmentation.
• PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study. 
• Product mapping in Excel for the key product of all major market players
• The report will provide access to approximately 61 market data tables, 64 figures, and close to 180 pages. 

DMI Opinion:

Instead of extensive comprehensive protein profiling, perhaps the most promising use of proteomics at the moment is the screening of particular categories of protein biomarkers for particular disorders. With the aid of these technologies, an era of individualized, patient-tailored therapy is quickly approaching. Moreover the growing advances and technologies by key players will lead to growth of proteomic market in coming future.

About Us:

DataM Intelligence 4Market Research is a market intelligence platform that gives access to syndicated, customized reports and consulting to its clients in one place. As a firm with rich experience in research and consulting across multiple domains, we are a one-stop solution that will cater to the needs of clients in key business areas. DataM Intelligence has an online platform whose coverage includes industries such as chemicals and materials, agriculture, health care services, animal feed, and food & beverages among others. Our platform has Insights on markets that uncover the latest market research data that are distinct from the competition. With coverage across 10 major industries in the marketplace research, DataM Intelligence benefits thousands of companies by helping them take their innovations early to the market by providing a complete view of the market with statistical forecasts. Our strategy centric framework and value-added services will let individuals and corporates with ease of access and custom personalization to research and markets.

Media Contact
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Send Email
Phone: 08774414866
Address:DATAM INTELLIGENCE 4MARKET RESEARCH LLP Ground floor, DSL Abacus IT Park, Industrial Development Area, Uppal, Hyderabad, Telangana 500039
City: HYDERABAD
State: Telangana
Country: India
Website: https://www.datamintelligence.com/research-report/proteomics-market